SCHEMBL14770567

SCHEMBL14770567

c1ccc2c(c1)c1ccccc1n2-c1ccc2oc3ccc(-c4cncc(-n5c6ccccc6c6cnccc65)c4)cc3c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.37
MAOB P27338 4/20 0.37
ACHE P22303 1/20 0.37
BTK Q06187 3/20 0.35
PIK3CD O00329 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35
PIK3CG P48736 2/20 0.35
PIK3R1 P27986 1/20 0.35
MTOR P42345 1/20 0.35
CYP2D6 P10635 1/20 0.33
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
AKT1 P31749 1/20 0.31
PGR P06401 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31
CYP19A1 P11511 1/20 0.30
NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770564 1.00 MAOA (0.37) MAOAMAOBACHEBTKPIK3CD
SCHEMBL14770572 0.93 BTK (0.35) BTKPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL14770554 0.93 KDM4E (0.36) BTKPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL10042919 0.93 MAOA (0.42) MAOAMAOBACHEBTKPIK3CD
SCHEMBL2628331 0.91 MAOA (0.39) MAOAMAOBACHEBTKPIK3CD
SCHEMBL2628387 0.90 MAOA (0.38) MAOAMAOBACHEBTKPIK3CD
SCHEMBL17484584 0.88 MAOA (0.36) MAOAMAOBACHEBTKPIK3CD
SCHEMBL10041333 0.88 KDM4E (0.38) BTKPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL12126328 0.88 BTK (0.37) MAOAMAOBACHEBTKPIK3CD
SCHEMBL14770681 0.88 PLA2G2A (0.36) BTKPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L MAOA 458/4885MAOB 432/4885ACHE 4246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.